BRISTOL MYERS SQUIBB

Pharmaceutical preparations for human use for the treatment and prevention of cardiovascular diseases, central nervous system diseases and disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, arthritis; Pharmaceutical preparations for human use, namely, antibiotics, immunosuppressants, immunotherapies for the treatment of cancer; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, including T Cell therapy

Pharmaceutical research and development services